Arcellx (ACLX) Free Cash Flow (2021 - 2025)
Arcellx (ACLX) recorded quarterly Free Cash Flow of -$60.0 million in Q4 2025, down 23.87% quarter-over-quarter from -$48.4 million in Q3 2025, and down 3.22% on a YoY basis from -$62.0 million in Q4 2024.
Arcellx (ACLX) Free Cash Flow (2021 - 2025) Analysis & Trends
Arcellx's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$60.0 million for Q4 2025.
- In Q4 2025, Free Cash Flow fell 3.22% year-over-year to -$60.0 million; the TTM figure through Dec 2025 stood at -$212.6 million (down 119.38% YoY), while the FY2025 annual figure was -$212.6 million, down 119.38% from the prior year.
- Free Cash Flow was -$60.0 million for Q4 2025 at Arcellx, down from -$48.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $179.3 million in Q1 2023 to a low of -$63.9 million in Q1 2025.
- Historically, Free Cash Flow has averaged -$14.2 million across 5 years, with a median of -$27.2 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 239.18% in 2022, then surged 642.56% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$26.5 million in 2021, then retreated by 5.22% to -$27.9 million in 2022, then jumped by 258.03% to $44.0 million in 2023, then tumbled by 232.04% to -$58.1 million in 2024, then dropped by 3.22% to -$60.0 million in 2025.
- The last three Free Cash Flow figures came in at -$60.0 million (Q4 2025), -$48.4 million (Q3 2025), and -$40.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 63,220.27 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -60.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60.00 Mn |
| Dec 31, 2025 | -60.00 Mn |
| Sep 30, 2025 | -48.44 Mn |
| Sep 30, 2025 | -48.44 Mn |
| Jun 30, 2025 | -40.22 Mn |
| Jun 30, 2025 | -40.22 Mn |
| Mar 31, 2025 | -63.93 Mn |
| Mar 31, 2025 | -63.93 Mn |
| Dec 31, 2024 | -58.13 Mn |
| Dec 31, 2024 | -58.13 Mn |
| Sep 30, 2024 | 39.03 Mn |
| Sep 30, 2024 | 39.03 Mn |
| Jun 30, 2024 | -43.39 Mn |
| Jun 30, 2024 | -43.39 Mn |
| Mar 31, 2024 | -34.42 Mn |
| Mar 31, 2024 | -34.42 Mn |
| Dec 31, 2023 | 44.03 Mn |
| Dec 31, 2023 | 44.03 Mn |
| Sep 30, 2023 | -9.10 Mn |
| Sep 30, 2023 | -9.10 Mn |